Smith & Nephew adds PELNAC dermal replacement wound product to its portfolio

Smith & Nephew (NYSE: SNN) (LSE: SN) Advanced Wound Management division, announces the agreement to partner with Gunze Limited, Japan and exclusively distribute PELNAC dermal replacement in Japan, South Africa, Australia and New Zealand.

PELNAC is a collagen matrix with silicone top layer for use on full thickness injuries such as burns and trauma. It helps promote the regeneration of damaged dermal layers as an alternative to using the patient's own dermis which may not be available with extensive injuries. PELNAC will be available from Smith and Nephew in Japan from January 1st, 2010, with South Africa and Australia following shortly after.

"I am delighted that we can add PELNAC to our portfolio," said Leon Hoare, President - Advanced Wound Management, Asia Pacific. "It provides a solution to the needs of many plastic and burn surgeons who deal with serious injuries and helps to support the patients with a good cosmetic outcome."

"The addition of PELNAC enhances our wound care offering for burns and trauma injuries," commented Roger Teasdale, President, Smith & Nephew Wound Management. "We are very pleased to be working with Gunze and look forward to the opportunities that lay ahead for both businesses."

Source:

Smith & Nephew PLC

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Growth hormone-releasing hormone transforms therapeutic potential in health and chronic disease